FINWIRES · TerminalLIVE
FINWIRES

美伊和平谈判破裂后,欧洲股市周一下跌。

-- 周一,受美国总统特朗普威胁封锁霍尔木兹海峡(此前美伊和平谈判破裂)的影响,欧洲股市下跌。 斯托克欧洲600指数、德国DAX 40指数和英国富时100指数均下跌0.2%,法国CAC 40指数下跌0.4%,瑞士市场指数下跌0.3%。 由于和平协议前景黯淡,国防类股上涨。达索系统公司股价在巴黎上涨3.6%,泰雷兹公司股价上涨2.4%;英国航空航天系统公司股价在伦敦上涨2.6%;莱茵金属公司股价在法兰克福上涨2.5%。 企业新闻方面,道达尔能源公司与土耳其国家能源公司TPAO签署了一份谅解备忘录,以寻求勘探机会。 这家法国石油和天然气公司的股价在巴黎上涨1.3%。 劳埃德银行集团正在推进英国金融行为监管局(FCA)的汽车金融赔偿计划。 这家英国银行的股价在伦敦下跌了0.4%。 葛兰素史克(GSK)周日表示,其抗体药物偶联物mocertatug rezetecan的I期临床试验显示,在铂类耐药卵巢癌患者中,该单药疗法在最高评估剂量下达到了62%的确认客观缓解率。 该研究还显示,该疗法在复发性或晚期子宫内膜癌患者中的缓解率为67%。 这家制药公司的股价在伦敦下跌了0.3%。 英国石油公司(BP)的纳米比亚分公司同意从Eco Atlantic公司收购三项海上勘探许可证60%的参与权益和作业权。 英国石油公司(BP)的股价在伦敦上涨了1%。

Related Articles

Equities

Petro Rabigh Emerges From Loss in Q1; Revenue Grows

Rabigh Refining and Petrochemical (SASE:2380), d/b/a Petro Rabigh, said Sunday it swung back to profit in the first quarter of 2026, while revenue increased year over year.Net profit attributable to shareholders of the issuer for the three months ended March 31 was 1.47 billion Saudi riyals, compared with the attributable loss of 691 million riyals earlier. EPS moved to 0.88 riyal from a loss per share of 0.41 riyal.The Tadawul-listed oil refining and petrochemical company's revenue was 14.85 billion riyals, compared with 11.21 billion riyals a year ago.

$SASE:2380
Research

Research Alert: CFRA Keeps Buy Opinion On Shares Of The Hartford Insurance Group, Inc.

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We trim our 12-month target price by $8 to $155, valuing HIG shares at 11.3x our 2026 operating EPS estimate of $13.75 (cut by $0.45) and at 10.6x our 2027 EPS estimate of $14.65 (cut by $0.30), vs. the shares' one-year average forward multiple of 10.3x and peer average of 13x. Q1 EPS of $3.09 vs. $2.20 a year ago missed our $3.60 estimate and $3.39 consensus view. Operating revenue growth of 6.2% was in line with our 6%-10% forecast, amid 5.3% earned premium growth, 13% higher net investment income, and 7.9% fee revenue growth. Q1 written premium growth of 4% and full-year 2025 growth of 7% bode well for 2026 revenue trends as premiums are earned. Underwriting results improved significantly, with Personal Lines combined ratio improving to 87.7% from 106.1% and underlying combined ratio to 85.0% from 89.7%. Business Insurance combined ratio was stable at 94.8%. Weighing the Q1 EPS miss with HIG's decent top-line growth and discounted valuation to peers, we view the shares as undervalued.

$HIG
Research

Research Alert: CFRA Keeps Strong Buy Opinion On Shares Of Baker Hughes

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We raise our 12-month target price by $14 to $82, reflecting a combination of our sum-of-the-parts (SOTP) and DCF models. For our SOTP model, we presume the oilfield services business (about 50% of BKR's franchise) to be valued at about 10x projected 2027 EBITDA (in line with major peers) and its industrial energy technology business (the other 50%) valued at 14x projected 2027 EBITDA (in line with the peer median). This blended approach, yielding a 12x multiple, implies a value of $73 per share. Meanwhile, our DCF model, using medium-term free cash flow growth of 5% per year, terminal growth of 2.5%, discounted at a WACC of 6.3%, yields intrinsic value of $91 per share. We cut our 2026 EPS estimate by $0.47 to $2.48, but we raise 2027's by $0.07 to $3.24. We acknowledge that the oilfield services business is likely to struggle in 2026 owing to the U.S.-Iran conflict, but the IET business appears quite robust and likely to be a source of both accelerating revenue growth and margins.

$BKR